Pilot Test of a Community-based Buprenorphine Treatment Intervention

Development of a Community-based Buprenorphine Treatment Intervention

The main goal of this study is to pilot test the community-based buprenorphine treatment (CBBT) intervention, examining buprenorphine treatment initiation, opioid use, and HIV risk behaviors. Two groups of participants will be followed for 60 days, with 3 research visits. One group will be enrolled prior to the CBBT intervention (pre-intervention), and one group after the CBBT intervention (post-intervention). Data sources will include questionnaires, urine toxicology tests, and medical record data. Investigators hypothesize that compared to the participants in the pre-intervention group, participants in the post-intervention group will be more likely to initiate buprenorphine treatment, reduce opioid use, and reduce high-risk HIV risk behaviors.

Inclusion Criteria:

• at least 18 years old
• English or Spanish fluency
• ever injected drugs
• not receiving buprenorphine treatment (no prescribed buprenorphine in the previous 6 months)
• clients of our collaborating community-based organization
• interested in buprenorphine treatment

Exclusion Criteria:

• pregnant
• taking more than 60mg of methadone daily in the previous 30 days